The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with reassurance, ...

The medication vibegron led to improvements in symptoms of overactive bladder and overall quality of life in men undergoing treatment for benign prostatic hyperplasia, according to findings from a ...

Thermobalancing therapy is an advanced medical technology known for its effective and safe approach to treating men wi ...

Storage symptoms favored the OAB group, despite comparable overall symptom improvement for those with, without OAB.

The FDA has expanded the use of a drug-coated balloon developed by Urotronic for male urinary procedures, which the company describes as one of the first of a new generation of devices in the space.

Before having Aquablation (water ablation) therapy, it is essential to check that the treatment, equipment, medical facility, and healthcare professional are Medicare-approved and that the person ...

LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom relief with no adverse effect on sexual function, long-term results from ...

The most common prostate condition in men over the age of 50 is benign prostatic hyperplasia, a noncancerous condition that impacts the prostate gland. BPH is when the prostate enlarges and constricts ...

The presence of scar tissue, periprostatic fibrosis, and inflammation due to previous surgery increases the complexity of some surgical tasks, according to investigators. Undergoing radical ...

New BPH Treatment At Memphis Vascular Center Offers Relief ...

Laborie Medical Technologies has taken another step in a steady cadence of acquisitions, picking up prostate balloon treatment maker Urotronic in a deal worth up to $600 million. The transaction ...